Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

Goldman Sachs Sees a Tough Backdrop for IT Stocks, but Says You Can Still Win with These 3 ‘Strong Buy’ Names

View original at finance.yahoo.com
Goldman Sachs Sees a Tough Backdrop for IT Stocks, but Says You Can Still Win with These 3 ‘Strong Buy’ Names Talk about tech these days, and most people will flash directly to AI…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Penguin Solutions' 25+ years of experience in high-performance computing will position the company favorably to address growing demand in enterprises, sovereigns/public sector, and neoclouds verticals.

    80% confidence
  • Goldman Sachs sees upside to Dell's outlook for AI server revenue to grow at a 20-25% CAGR from FY2026 to FY2030 at mid single digit percent EBIT margins.

    80% confidence
  • Dell will continue to be a leader in the AI server OEM market for neocloud customers, supported by differentiated engineering expertise and services capabilities.

    80% confidence
  • Goldman Sachs rates Dell a Buy with a 12-month price target of $165, implying 48.5% upside.

    80% confidence
  • TD Synnex has a goal of returning 50-75% of free cash flow to shareholders in buybacks and dividends, though ramping Hyve may weigh on near-term free cash flow generation.

    80% confidence
  • Goldman Sachs is selectively positive on IT hardware stocks best exposed to categories still in the expansion phase of their multi-year refresh cycle, specifically x86 servers, enterprise storage, and campus networking.

    80% confidence
  • Dell carries a Strong Buy consensus rating based on 16 analyst reviews: 13 Buys, 2 Holds, 1 Sell, with average price target of $164

    80% confidence
  • Penguin Solutions' non-hyperscaler Penguin Computing business was up 75% year-over-year in fiscal 2025.

    80% confidence
  • Penguin Solutions Integrated Memory business F2026 revenue expected to grow 20-35% YoY from higher industry pricing in supply-constrained environment

    80% confidence
  • Hyve billings growth will continue to outpace the overall TD Synnex company driven by ramping programs with its two existing hyperscale customers.

    80% confidence
  • Penguin Solutions' AI infrastructure momentum within its core customer base is encouraging, with non-hyperscaler Penguin Computing business up 75% YoY in F2025

    80% confidence
  • TD Synnex carries a Strong Buy consensus rating based on 7 reviews (6 Buys, 1 Hold), with average price target of $178.57

    80% confidence
  • Penguin Solutions has a unanimous Strong Buy consensus rating based on 4 recent positive analyst reviews, with an average price target of $25.75.

    80% confidence
  • Dell's self-help actions to gain profitable share should partially offset any consolidated margin pressure from greater AI server mix or increased commodity costs

    80% confidence
  • Goldman Sachs sees upside to Dell's AI server revenue outlook to grow at 20-25% CAGR (F2026-30) at mid-single-digit EBIT margins, driven by upward capex revisions from tier-two cloud providers and demand from sovereign and enterprise customers

    80% confidence
  • Goldman Sachs rates Penguin Solutions a Buy with a $25 price target suggesting 27% upside.

    80% confidence
  • TD Synnex's core distribution business is well positioned to benefit from growth in IT spending driven by the ongoing refresh in campus networking and traditional data center infrastructure.

    80% confidence
  • Dell's self-help actions to gain profitable share should partially offset any consolidated margin pressure from greater AI server mix or increased commodity costs.

    80% confidence
  • Penguin Solutions' 25+ years of HPC experience will position the company favorably to address growing demand in enterprises, sovereigns/public sector, and neoclouds verticals

    80% confidence
  • Goldman Sachs rates Dell as Buy with a 12-month price target of $165

    80% confidence
  • Dell Technologies has a Strong Buy consensus rating based on 16 analyst reviews: 13 Buys, 2 Holds, 1 Sell, with an average price target of $164.

    80% confidence
  • TD Synnex's Hyve billings growth will continue to outpace the overall company driven by ramping programs with its two existing hyperscale customers

    80% confidence
  • TD Synnex has a Strong Buy consensus rating from 7 analyst reviews (6 Buys, 1 Hold), with an average price target of $178.57.

    80% confidence
  • Penguin Solutions carries a unanimous Strong Buy consensus rating based on 4 recent positive analyst reviews, with average price target of $25.75

    80% confidence
  • Dell will continue to be a leader in the AI server OEM market for neocloud customers, supported by differentiated engineering expertise and services capabilities

    80% confidence
  • TD Synnex has a strong free cash flow profile with a goal of returning 50-75% of FCF to shareholders in buybacks and dividends, though ramping Hyve may weigh on FCF generation near term

    80% confidence
  • Goldman Sachs rates TD Synnex a Buy with a $180 price target indicating 23% upside potential.

    80% confidence
  • Goldman Sachs rates Penguin Solutions as Buy with a $25 price target implying 27% upside

    80% confidence
  • Goldman Sachs rates TD Synnex as Buy with a $180 price target indicating 23% potential upside

    80% confidence
  • Penguin Solutions' Integrated Memory business fiscal 2026 revenue is expected to grow 20-35% year-over-year, benefiting from higher industry pricing in a supply-constrained environment.

    80% confidence

Data points we hold from this source

Dell Technologies · market cap80 billion_USD
Dell Technologies · revenue27 billion_USD
Dell Technologies · eps2.59 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,372 source documents archived
Query this data → isubstrate.com
Goldman Sachs Sees a Tough Backdrop for IT Stocks, but Says You Can Still Win with These 3 ‘Strong Buy’ Names — Source | Via News | Via News